DVS Sciences, Inc.

5AM Ventures focuses on building next-generation life science companies capable of delivering outstanding returns to their investors. the firm support companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science. their portfolio companies spearhead novel approaches to diagnose, prevent and treat a wide range of medical conditions. the firm employs a time-tested, hands-on approach to company-building and, in addition to being an early investor, they often involve in setting company strategy, management recruiting, business development and fundraising. they contribute as board members and frequently take on short-term operating roles.

Pfizer Venture Investments focuses on investments in emerging companies that are developing or compounding technologies that have the potential to enhance Pfizer's pipeline and shape the future of our industry. The firm focuses on healthcare related areas, including therapeutics, platform technologies, diagnostics, drug delivery, pharmaceutical services, healthcare IT, and other technologies impacting drug discovery and development.Pfizer Venture Investments may invest up to $10 million per round in selected companies at any stage of development including start-ups, spinouts and consortia investments with emphasis on growth stage opportunities. Other investments, including fund investing, spinout opportunities and PIPEs are also be considered as appropriate. They have the ability to lead or join a syndicate of investors and they take seat on the board of directors.

Professional at Fluidigm Corp.